268 related articles for article (PubMed ID: 35610002)
1. Antiviral Activity of Medicinal Plants against Human Coronavirus: a systematic scoping review of and experimentations.
Namiranian P; Sadatpour O; Azimzadeh Jamalkandi S; Hossein Ayati M; Karimi M
J Tradit Chin Med; 2022 Jun; 42(3):332-343. PubMed ID: 35610002
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
Idrees M; Khan S; Memon NH; Zhang Z
Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
[TBL] [Abstract][Full Text] [Related]
4. An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects.
Jamshidnia M; Sewell RDE; Rafieian-Kopaei M
Curr Pharm Des; 2022; 28(29):2415-2425. PubMed ID: 35899955
[TBL] [Abstract][Full Text] [Related]
5. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
6. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.
Llivisaca-Contreras SA; Naranjo-Morán J; Pino-Acosta A; Pieters L; Vanden Berghe W; Manzano P; Vargas-Pérez J; León-Tamariz F; Cevallos-Cevallos JM
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279439
[TBL] [Abstract][Full Text] [Related]
7. Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities.
Hafez Ghoran S; El-Shazly M; Sekeroglu N; Kijjoa A
Molecules; 2021 Mar; 26(6):. PubMed ID: 33800977
[TBL] [Abstract][Full Text] [Related]
8. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.
Joseph J; Karthika T; Das VRA; Raj VS
Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189
[TBL] [Abstract][Full Text] [Related]
9. Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis.
Ebenezer O; Bodede O; Awolade P; Jordaan MA; Ogunsakin RE; Shapi M
Acta Pharm; 2022 Jun; 72(2):199-224. PubMed ID: 36651508
[TBL] [Abstract][Full Text] [Related]
10. Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery.
Amin SA; Ghosh K; Singh S; Qureshi IA; Jha T; Gayen S
Mol Divers; 2022 Feb; 26(1):215-228. PubMed ID: 33675510
[TBL] [Abstract][Full Text] [Related]
11. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
[TBL] [Abstract][Full Text] [Related]
12. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
Báez-Santos YM; St John SE; Mesecar AD
Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
[TBL] [Abstract][Full Text] [Related]
13. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
14. Herbal Medicines to Fight Against COVID-19: New Battle with an Old Weapon.
Harwansh RK; Bahadur S
Curr Pharm Biotechnol; 2022; 23(2):235-260. PubMed ID: 33749558
[TBL] [Abstract][Full Text] [Related]
15. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review.
Adhikari B; Marasini BP; Rayamajhee B; Bhattarai BR; Lamichhane G; Khadayat K; Adhikari A; Khanal S; Parajuli N
Phytother Res; 2021 Mar; 35(3):1298-1312. PubMed ID: 33037698
[TBL] [Abstract][Full Text] [Related]
16. Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.
Gogoi M; Borkotoky M; Borchetia S; Chowdhury P; Mahanta S; Barooah AK
J Biomol Struct Dyn; 2022 Sep; 40(15):7143-7166. PubMed ID: 33715595
[TBL] [Abstract][Full Text] [Related]
17. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
[TBL] [Abstract][Full Text] [Related]
18. A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2.
Guguloth SK; Lakshmi AR; Rajendran R; Rajaram K; Chinnasamy T; Huang JD; Zhang H; Senapati S; Durairajan SSK
Curr Drug Targets; 2022; 23(8):818-835. PubMed ID: 34636297
[TBL] [Abstract][Full Text] [Related]
19. Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.
Zhao Y; Deng S; Bai Y; Guo J; Kai G; Huang X; Jia X
Phytother Res; 2022 Oct; 36(10):3833-3858. PubMed ID: 35932157
[TBL] [Abstract][Full Text] [Related]
20. In Silico Identification of Anti-SARS-CoV-2 Medicinal Plants Using Cheminformatics and Machine Learning.
Liang J; Zheng Y; Tong X; Yang N; Dai S
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
